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Xenopus oocyte death is partly controlled by the
apoptotic initiator caspase-2 (C2).We reported previ-
ously that oocyte nutrient depletion activates C2
upstream of mitochondrial cytochrome c release.
Conversely, nutrient-replete oocytes inhibit C2 via
S135 phosphorylation catalyzed by calcium/calmod-
ulin-dependent protein kinase II. We now show that
C2 phosphorylated at S135 binds 14-3-3z, thus pre-
venting C2 dephosphorylation. Moreover, we deter-
mined that S135 dephosphorylation is catalyzed by
protein phosphatase-1 (PP1), which directly binds
C2. Although C2 dephosphorylation is responsive to
metabolism, neither PP1 activity nor binding is meta-
bolically regulated. Rather, release of 14-3-3z from
C2 is controlled by metabolism and allows for C2
dephosphorylation. Accordingly, a C2mutant unable
to bind 14-3-3z is highly susceptible to dephosphor-
ylation. Although this mechanism was initially estab-
lished in Xenopus, we now demonstrate similar
control of murine C2 by phosphorylation and 14-3-3
binding in mouse eggs. These findings provide an
unexpected evolutionary link between 14-3-3 and
metabolism in oocyte death.
INTRODUCTION
Apoptosis is a form of programmed cell death characterized by
activation of cysteine proteases known as caspases, which
dismantle the cell in an orderly, energy-dependent manner. Cas-
pases are divided into two classes, initiator or effector, based on
their position in the apoptotic hierarchy. Initiator caspases (e.g.,
caspase-2 [C2], -8, and -9) occupy the apical position in cell
death pathways and are activated by dimerization, which
involves recruitment of adaptor proteins to the caspase prodo-
main (pro) via homotypic interactions between their respective
caspase recruitment domains (Danial and Korsmeyer, 2004).856 Developmental Cell 16, 856–866, June 16, 2009 ª2009 ElsevierOnce active, initiator caspases cleave and activate effector cas-
pases to promote apoptosis.
In response to certain apoptotic cues, C2 activation occurs
on a platform consisting of the adaptor protein RIP-associated
IHC-1/CED-3-homologous protein with a death domain (RAIDD),
which binds directly to the C2 pro, and p53-induced protein with
a death domain (PIDD), which oligomerizes RAIDD (Baliga et al.,
2004; Duan and Dixit, 1997; Read et al., 2002; Tinel and
Tschopp, 2004). PIDD expression is p53 inducible, and has
been linked to genotoxic stress (Hanoux et al., 2007; Panaretakis
et al., 2005; Robertson et al., 2002). Whether and how RAIDD or
PIDDmight be regulated posttranslationally to control apoptosis
is unknown.
The nutrient status of a cell may be important in the decision to
initiate apoptosis. Decreased glucose uptake and glycolytic rate
occur upon growth factor withdrawal in lymphocytes, and this
precedes commitment to caspase activation (Rathmell et al.,
2003). Artificial maintenance of glycolysis confers apoptotic
resistance under these conditions (Zhao et al., 2007). Further-
more, AKT kinase exerts an antiapoptotic effect in many cell
types and requires glucose uptake in order to do so (Majewski
et al., 2004; Pastorino et al., 2002; Rathmell et al., 2003; Zhao
et al., 2007). When hexokinase is bound to mitochondria, it can
suppress the proapoptotic release of mitochondrial cytochrome
c (cyt c) (Majewski et al., 2004; Pastorino et al., 2002). It has also
been demonstrated that the proapoptotic Bcl-2 family member,
Bcl-xL/Bcl-2-associateddeathpromoter (BAD), formsacomplex
with and regulates the activity of glucokinase at themitochondria
(Danial et al., 2003).
We reported previously that nutrient depletion in Xenopus
oocytes promotes apoptosis through activation of C2 (Nutt
et al., 2005). This is particularly interesting in light of work
demonstrating that the primary phenotype of C2-knockout
mice is excess oocytes in females, suggesting that oocytes
might be particularly susceptible to C2-mediated death (Ber-
geron et al., 1998). In exploring links between metabolism and
C2, we discovered that maintenance of NADPH levels by flux
through the pentose phosphate pathway (PPP) induces
a suppressive phosphorylation of Xenopus C2 on S135. A non-
phosphorylatable mutant of C2 (S135A) induced apoptosis
even in the presence of high levels of NADPH.Inc.
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14-3-3z Regulates Caspase-2 ActivationIn analyzing regulation of C2, we found that NADPH promotes
activation of calcium/calmodulin-dependent protein kinase II
(CaMKII), which catalyzes S135 phosphorylation. Thus, for
oocytes to undergo apoptosis upon nutrient depletion
(decreasing PPP flux), a phosphatase must be required to
dephosphorylate C2. Although a large number of kinases have
been implicated in apoptotic regulation, potential links between
phosphatases and cell death are poorly understood. For protein
phosphatases-1 and -2A, specificity is typically conferred by
a targeting subunit, which either directs the catalytic subunit to
its substrates or alters its subcellular localization (Cohen, 2002;
Shenolikar, 1994). Recently, however, it has been shown that
the PP1 catalytic subunit may also bind directly to substrates
via substrate motifs similar to those found on targeting subunits
(Margolis et al., 2003; Vietri et al., 2006). In these cases, targeting
subunits may be dispensable for dephosphorylation. Regulation
of PP1 activity and specificity may furthermore occur through
PP1 binding to inhibitory proteins (I1, I2), and substrate dephos-
phorylation may also be modulated by additional posttransla-
tional modifications and/or binding partners. We recently
reported this mechanism for the cell cycle phosphatase Cdc25
(Margolis et al., 2006). In this example, 14-3-3 protein binds to
Cdc25, masking PP1 access to phospho-S287. Cdc25 remains
phosphorylated and suppressed until 14-3-3 dissociates, thus
leaving S287 vulnerable to PP1 (Margolis et al., 2003, 2006).
Although NADPH is required for apoptotic suppression in the
oocyte, it is not known if C2 activation might also be a locus of
metabolic control. We now demonstrate that PP1-mediated C2
dephosphorylation is required for C2 activation, and dephos-
phorylation is indirectly regulated by PPP flux. In searching for
novel C2 pro interactors, we discovered that 14-3-3z binds the
C2 pro. Moreover, S135 dephosphorylation, which is required
for C2 activation, depends upon removal of 14-3-3z. Importantly,
14-3-3z removal is under tight metabolic control; stimulation of
the PPP results in 14-3-3z binding, and nutrient depletion
promotes 14-3-3z release. Finally, we have also uncovered
evidence of a parallel regulatory C2 activation pathway in
mammalian oocytes, in that perturbation of murine C2 phos-
phorylation or 14-3-3 binding appears to control the viability of
mouse eggs. These data provide evidence that the metabolic
regulation of C2 activation depends upon an evolutionarily
conserved association with 14-3-3, and this association medi-
ates the phosphorylation status and activity of C2 during
apoptosis in the oocyte.
RESULTS
Metabolic Suppression of C2 Dephosphorylation
Our previous work indicated that nutrient abundance inhibited
C2 through CaMKII-mediated S135 phosphorylation. These
findings, coupled with observations placing C2 upstream of
mitochondrial cyt c release, implied that C2 should be dephos-
phorylated prior to caspase-3 (C3) activation. To evaluate this,
we monitored the phosphorylation status of endogenous C2 in
egg extracts using an antibody directed against phosphorylated
S135 (Figure 1A). EndogenousC2was immunoprecipitated using
either a Xenopus C2 antibody directed against the C-terminal 20
amino acids of the protein or the corresponding preimmune
serum, and immunoprecipitates were analyzed for C2 pS135.DevThisexperimentwasperformed in thepresenceof theC2 inhibitor,
N-acetyl-Val-Asp-Val-Ala-Asp-CHO (aldehyde) (VDVAD-CHO), to
ensure that loss of C2 pS135 was not due to C2 processing. As
shown in Figure 1B, endogenous C2 was dephosphorylated at
S135 over time, and this preceded C3 activation.
These observations raised the interesting possibility that an
S135-directed phosphatase might be regulated by metabolism,
thus activating C2 upon nutrient depletion. To examine C2
dephosphorylation in isolation, we prepared radiolabeled,
S135-phosphorylated C2 pro fused to glutathione S-transferase
(GST) as a dephosphorylation substrate. Incubation of this
construct in egg extract resulted in dephosphorylation of C2
S135 immediately preceding C3 activation, as would be ex-
pected if C2 dephosphorylation was required for its own activa-
tion and downstream caspase activity (Figure 1C; the time
course of C3 activation differs between extracts, but C2 dephos-
phorylation prior to C3 activation was consistent across multiple
extracts). Whenwe repeated this assay in the presence of G6P to
increase PPP activity, C2 dephosphorylation and C3 activation
were inhibited (Figure 1D; see Figure S1 in the Supplemental
Data available online). These data suggest that C2 dephosphor-
ylation and activation were under metabolic control.
Wealsoshow that dephosphorylation ofGST-C2propreceded
C2 activation, as demonstrated by processing of in vitro trans-
lated full-length C2 (Figure 1E). These data suggest that both
endogenous full-length and isolated pro C2 were dephosphory-
lated at S135 over time, and this preceded C2 processing and
C3 activation.
PP1 Interacts with C2 Prodomain
To identify the phosphatase responsible for C2 dephosphoryla-
tion, we titrated the phosphatase inhibitor okadaic acid (OA) into
extracts and monitored C3 activation, mitochondrial cyt c
release, GST-C2 pro dephosphorylation, and full-length C2 pro-
cessing (Figures 2A–2C). OA follows a biphasic dose-response
curve in the extract, with nanomolar/lowmicromolar doses inhib-
iting PP2A and higher (10 mM) concentrations inhibiting PP1
(Margolis et al., 2003). OA doses known to inhibit PP1, but not
those inhibiting only PP2A, abrogated C3 activation, cyt c
release, and C2 dephosphorylation (Figures 2A and 2B); 10 mM
OA also prevented processing of full-length C2 (Figure 2C).
These data (and the fact that >95% of OA-inhibitable phospha-
tases in the extract is PP1 or PP2A) strongly suggested that
PP1 might dephosphorylate C2 S135.
To confirm that PP1 was the S135-directed phosphatase, we
depleted extract of endogenous PP1 using GST-I2 as an affinity
resin andmonitored samples forGST-C2pro dephosphorylation.
As shown in Figure 2D, PP1 depletion markedly inhibited C2
dephosphorylation. Also consistent with a role for PP1, GST-C2
pro was able to bind PP1 in extracts but not PP2A (Figure 2E),
and we also did not observe binding to the OA-inhibitable phos-
phatase PP5 (data not shown). Additionally, endogenous C2
coimmunoprecipitated with endogenous PP1 (Figure 2G).
PP1 is commonly directed to its substrates by a targeting
subunit (Cohen, 2002). We reasoned that a targeting subunit
involved in C2 dephosphorylation would be a component of
the PP1-C2 complex. Thus, GST-C2 pro was incubated in
extract and bound proteins were analyzed via far-Western assay
with digoxigenin-labeled PP1. Interestingly, we did not seeelopmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevier Inc. 857
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14-3-3z Regulates Caspase-2 Activationbinding of PP1 to any protein in the affinity precipitate other than
C2 pro itself (data not shown). These data were reminiscent of
those from previous work from our laboratory demonstrating
that PP1 directly binds Cdc25 in the absence of a targeting
subunit (Margolis et al., 2003). Similar results have also been
reported for the retinoblastoma protein (Vietri et al., 2006). There-
fore, we hypothesized that PP1 might mediate S135 dephos-
phorylation through direct C2 binding. To test this, we examined
the interaction between GST-C2 pro and recombinant PP1 cata-
lytic domain. As shown in Figure 2F (right two lanes), GST-C2 pro
bound directly to recombinant PP1 in vitro, consistent with the
Figure 1. C2 S135 Dephosphorylation Is
Sensitive to Metabolism
(A) Glutathione Sepharose-bound GST-C2 pro
WT or S135A was phosphorylated in vitro with or
without recombinant CaMKII. Samples were
resolved by SDS-PAGE and immunoblotted using
an antibody specific to Xenopus C2 pS135.
(B) Anti-C2 and its corresponding preimmune
serum were titrated to determine equal IgG load-
ing (upper panel). Extracts treated with 100 mM
VDVAD-CHO were immunoprecipitated at the
indicated time points for 1 hr using preimmune-
or C2-IgG bound to Dynabeads Protein A.
Samples were resolved by SDS-PAGE and
immunoblotted for C2 pS135 (second panel from
top). In parallel, extracts were analyzed for pro-
cessing of radiolabeled in vitro-translated full-
length C2 or C3 activity (lower two panels). White
arrow, full-length C2; IP, immunoprecipitate; PI,
preimmune; n = 3.
(C) Left panel: extracts were analyzed for C3
activity over time using the caspase substrate,
Ac-DEVD-pNA. Right panel: in parallel, GST-C2
pro was prephosphorylated with CaMKII and
[g-32P]ATP; Sepharose-boundproteinswere incu-
bated in extract over time and samples were
resolved by SDS-PAGE and detected by autoradi-
ography. Data are demonstrated quantitatively in
the left panel (a representative experiment of n=5).
(D) Glutathione Sepharose-bound GST-C2 pro
was prephosphorylated with [g-32P]ATP as
described in (A), and Sepharose-bound proteins
were incubated in extract with or without G6P.
Samples were taken over time and detected by
autoradiography. In parallel, extracts with or
without G6P were analyzed for C3 activity using
Ac-DEVD-pNA (Supplemental Data); n = 3.
(E) Top panel: GST-C2 pro pS135 was analyzed
over time as described in (A). Middle panel: in
parallel, processing of full-length C2 was exam-
ined by autoradiography. Quantitation is provided
(bottom panel). White arrow, full-length C2; a
representative experiment of n = 3.
idea that PP1 and C2 interact in the
absence of a targeting subunit.
PP1 Binding Is Required
for C2 Activation
Only a handful of PP1 substrates have
been shown to bind PP1 directly (Margo-
lis et al., 2003; Vietri et al., 2006). Anal-
yses of PP1 binding motifs on direct substrates and targeting
subunits have identified VxF as a PP1 docking site (Egloff
et al., 1997; Wakula et al., 2003). We scanned C2 pro for VxF
motifs and failed to identify a candidate; however, we mutated
several valines and downstream residues in the hope that these
residues might cooperate to confer PP1 docking. As shown in
Figures 3A and 3B, mutation of V18/L20 and V106/H108 demon-
strated that V106A/H108A disrupted PP1 binding both in extract
and in buffer. This doublemutant was phosphorylated byCaMKII
to the same extent as wild-type (WT) (Figure 3C). To determine
if PP1 binding was essential for C2 dephosphorylation, we858 Developmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevier Inc.
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14-3-3z Regulates Caspase-2 ActivationFigure 2. C2 Dephosphorylation Is Medi-
ated by PP1
(A) Left panel: control- or OA-treated extracts
were analyzed for C3 activity with the substrate
Ac-DEVD-pNA. Right panel: Cyt c release was
measured in control- or OA-treated samples.
Cytosol was analyzed by SDS-PAGE and immu-
noblotted with an anti-cyt c antibody and anti-
actin; n = 3.
(B) GST-C2 pro bound to glutathione Sepharose
was prephosphorylated with [g-32P]ATP. Sephar-
ose-bound proteins were incubated in extracts
with or without OA, and samples were resolved
by SDS-PAGE and detected by autoradiography
(n = 3).
(C) Extracts were treated with OA and processing
of radiolabeled full-length C2 was examined by
autoradiography.White arrow, full-lengthC2; n=3.
(D) Glutathione Sepharose-bound GST-C2 pro
was prephosphorylated with [g-32P]ATP. In
parallel, extracts were depleted of endogenous
PP1 with GST- or GST-I2 (left panel). Prephos-
phorylated GST-C2 prowas incubated in depleted
extracts, andsampleswere retrievedover timeand
detected by autoradiography (right panel) (n = 4).
(E) Glutathione Sepharose-bound GST or GST-
C2 pro was incubated in extract and affinity-puri-
fied proteins were resolved by SDS-PAGE and
immunoblotted for PP1. The membrane was
coprobed for PP2A. In, input; NS, nonspecific.
(F) First four lanes: glutathione Sepharose-bound GST or GST-C2 pro was incubated in extract with or without G6P and affinity-purified proteins were resolved
by SDS-PAGE and immunoblotted for PP1. Right two lanes: glutathione Sepharose-bound GST or GST-C2 pro was incubated in buffer with recombinant PP1
catalytic domain. Sepharose-bound proteins were resolved by SDS-PAGE and immunoblotted for PP1.
(G) Anti-C2 and its corresponding preimmune serum were titrated to determine equal IgG loading (left panel). Extracts were immunoprecipitated using preim-
mune- or C2-IgG bound to Dynabeads Protein A. Immunoprecipitates were resolved by SDS-PAGE and immunoblotted for PP1; rabbit IgG heavy chain is also
shown. In, input; IP, immunoprecipitate; PI, preimmune.assayed dephosphorylation of these mutants over time. We
found that V106A/H108A was markedly refractory to dephos-
phorylation, while V18A/L20A was rapidly dephosphorylated
(Figure 3D). Moreover, V18A/L20A demonstrated metabolic
regulation similar toWTC2 pro (Figure 3D). Consistent with these
observations, microinjection of flag-tagged, full-length C2
V106A/H108A mRNA into Xenopus oocytes did not effectively
induce death, whereas an equivalent amount of WT protein
readily killed the oocytes (Figures 3E and 3F).
Although C2 dephosphorylation was under metabolic control
and mediated by PP1, this did not necessarily indicate that this
interaction was controlled by metabolism. Therefore, we wished
to determine whether PP1 bound C2 constitutively or whether
binding was induced just prior to caspase activation. As shown
in Figure 3G, GST-C2 pro bound PP1 constitutively, and binding
was not reduced by G6P (also see Figure 2F, first four lanes).
More importantly, when His-tagged PP1 was incubated in
control or G6P-treated extracts, retrieved, and then incubated
with CaMKII-phosphorylated GST-C2 pro in vitro, we saw that
C2 was dephosphorylated to a similar degree, regardless of
G6P treatment (Figure 3H, first four lanes). Thus, although C2
dephosphorylation was metabolically regulated, regulation was
not at the level of phosphatase activity or binding.
14-3-3z Binds C2
Since C2 dephosphorylation was regulated by metabolism, but
the C2/PP1 interaction and PP1 activity were not, we hypothe-Devesized that an additional factor(s) must be involved. To identify
C2 interactors, we used C2 pro as bait in a yeast two-hybrid
screen and identified the phosphoserine binding protein, 14-3-
3z. In agreement with this finding, we determined that GST-C2
pro bound endogenous 14-3-3 in G6P-treated extract
(Figure 4A). In a converse experiment, it was determined that
binding of endogenous C2 to GST-14-3-3z, but not 3, was
enhanced in the presence of G6P (Figure 4B); however, there
did appear to be some constitutive background binding to
14-3-33. Given this observation, we confirmed that 14-3-3z pref-
erentially bound CaMKII-phosphorylated C2 by phosphorylating
GST-C2 pro at S135 in vitro and incubating it with different
14-3-3 isoforms. We show in Figure 4C that GST-C2 pro
pS135 bound 14-3-3z, but not a 14-3-3z mutant unable to bind
target proteins (14-3-3z K49E), or 14-3-33 (Zhang et al., 1997).
These results suggest that C2 selectively binds 14-3-3z when
nutrients are abundant.
These observations raised the possibility that binding of
14-3-3z might control C2 activation. In this regard, it was inter-
esting that release of prebound endogenous 14-3-3z from
GST-C2 pro in extract was observed to occur before C3 activa-
tion (Figure 4D). Furthermore, addition of excess His-14-3-3z
blocked full-length C2 processing, whereas equal amounts of
14-3-3z K49E or 14-3-33 were unable to do so (Figure 4E).
Finally, addition of excess 14-3-3z to extract also prevented
C3 activation (Figure 4F). These data suggest that 14-3-3z
binding might, indeed, control C2 activation.lopmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevier Inc. 859
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14-3-3z Regulates Caspase-2 ActivationFigure 3. PP1 Binding Is Required for C2
Activation
(A) Glutathione Sepharose-bound GST-C2 pro
WT, V18A/L20A, or V106A/H108A was incubated
in extract, resolved by SDS-PAGE, and immuno-
blotted for PP1. NS, nonspecific.
(B) Glutathione Sepharose-bound GST-C2 pro
WT, V18A/L20A, or V106A/H108A was incubated
in buffer with recombinant PP1 catalytic domain.
Sepharose-bound proteins were resolved by
SDS-PAGE and immunoblotted for PP1. NS,
nonspecific.
(C) Glutathione Sepharose-bound GST, GST-C2
pro WT, or V106A/H108A was prephosphorylated
with [g-32P]ATP. Samples were resolved by SDS-
PAGE and examined by autoradiography. Black
arrow, GST-C2 pro; white arrow, GST.
(D) Glutathione Sepharose-bound GST-C2 pro
V106A/H108A or V18A/L20A was prephosphory-
lated with [g-32P]ATP and incubated in extract
with or without G6P. Samples were resolved by
SDS-PAGE and detected by autoradiography
(n = 3).
(E) Flag-tagged full-length C2 WT or V106A/
H108A mRNA was incubated in translationally
competent extract plus 100 mM VDVAD-CHO.
Translated flag-tagged C2 was retrieved with
anti-flag agarose and samples were analyzed by
immunoblotting with anti-flag.
(F) Percent survival of Xenopus oocytes microin-
jected with b-globin, full-length C2 WT, or
V106A/H108A mRNA. Equivalent levels of C2
mRNA expression were determined as described
in (E) (a representative experiment of n = 3).
(G) Glutathione Sepharose-bound GST-C2 pro
was incubated in extract with or without G6P,
and samples were retrieved over time and immu-
noblotted for PP1 and GST (n = 3).
(H) Glutathione Sepharose-bound GST-C2 pro
was prephosphorylated with [g-32P]ATP and
incubated in buffer with His-PP1 preincubated
in extract with or without G6P or excess His-
14-3-3z (27 mM). Samples were analyzed by
SDS-PAGE and autoradiography. Black arrow,
GST-C2 pro; white arrow, His-PP1; n = 4.14-3-3z Binding Regulates C2 Dephosphorylation
As described above, our laboratory reported that cell cycle-regu-
lated activation of Cdc25 depends upon 14-3-3 release (Margolis
etal., 2003,2006).Wespeculated thatC2dephosphorylationmight
alsobe regulatedat the levelof 14-3-3 release,particularlybecause
PP1 did not appear to be undermetabolic control. To address this,
we first examined the timing of 14-3-3 release from GST-C2 pro
compared to dephosphorylation. As shown in Figure 5A, 14-3-3z
released from C2 pro prior to maximal C2 dephosphorylation.
Next, we examined GST-C2 pro dephosphorylation in the pres-
ence of excess His-14-3-3z WT or K49E. We saw that prephos-
phorylated GST-C2 pro was dephosphorylated in control extract
or extract with 14-3-3z K49E, but dephosphorylation was signifi-
cantly decreased in the presence of excess 14-3-3z WT
(Figure 5B). This experiment suggests that the inhibitory effect of
14-3-3zonC2 isdirectly related to the interaction between the two.860 Developmental Cell 16, 856–866, June 16, 2009 ª2009 ElsevierMutation of GST-C2 pro S135 to Ala abrogated 14-3-3z
binding through loss of the phosphoserine docking site, and
binding was also lost when C2 pro D137 was mutated to Ala,
thus disrupting the downstream sequence required for efficient
interaction (Figure 5C). It is important to note that the C2/14-3-
3z binding motif is noncanonical in nature: classical 14-3-3
binding sequences are defined as RSXpSXP (mode I) and
RXY/FXpSXP (mode II), although the literature suggests consid-
erable binding site degeneracy (Rittinger et al., 1999; Yaffe et al.,
1997; Yang et al., 2006). Although canonical motifs are thought
to confer high-affinity binding, 14-3-3 interactions with atypical
motifs may result in binding subject to novel regulation, which
appears to be the case for metabolic regulation of C2 (Yaffe
et al., 1997).
If 14-3-3z binding controlled C2 dephosphorylation, we would
expect C2 D137A to be dephosphorylatedmore rapidly thanWT.Inc.
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(A) Glutathione Sepharose-bound GST or GST-C2
pro was incubated in extract plus G6P. Affinity-
purified proteins were resolved by SDS-PAGE
and immunoblotted with a pan-14-3-3 antibody.
Black arrow, GST-C2 pro; white arrow, GST.
(B) Glutathione Sepharose-bound GST, GST-14-
3-33, or GST-14-3-3z was incubated in extract
with or without G6P, and Sepharose-bound
proteins were resolved by SDS-PAGE and immu-
noblotted for Xenopus C2.
(C) Glutathione Sepharose-bound GST-C2 pro
was phosphorylated at S135 and incubated with
control conditions, His-14-3-3z WT, His-14-3-3z
K49E, or His-14-3-33 in buffer. Sepharose-bound
proteins were analyzed by SDS-PAGE and
immunblotted with a pan-14-3-3 antibody. In,
input.
(D) Upper panel: extracts were analyzed for C3
activity using the caspase substrate, Ac-DEVD-
pNA. Lower panel: in parallel, glutathione Sephar-
ose-bound GST-C2 pro was incubated in extract
plus G6P to promote binding of endogenous
14-3-3z, and this construct was then incubated
in fresh extract. Samples were retrieved and
analyzed for 14-3-3 binding (a representative
experiment of n = 4).
(E) Extract was incubated with radiolabeled full-
length in vitro-translated C2 in the presence of
control conditions, His-14-3-3z WT, His-14-3-3z
K49E, or His-14-3-33. Samples were analyzed
for C2 processing by autoradiography. White
arrow, full-length C2; n = 3.
(F) Extracts with or without His-14-3-3z WT were
analyzed for C3 activity using the caspase
substrate Ac-DEVD-pNA (a representative exper-
iment of n = 3).We first confirmed that CaMKII was able to phosphorylate
GST-C2 pro WT and D137A to the same extent in vitro
(Figure 5D). Next, GST-C2 pro WT or D137A was prephosphory-
lated with CaMKII and incubated in extract, and GST-C2 pro
phosphorylation status was assessed. As shown in Figure 5E,
C2 D137A was dephosphorylated more rapidly thanWT, consis-
tent with a role for 14-3-3z in inhibition of C2 dephosphorylation.
We also depleted extract of PP1 using GST-I2, demonstrating
that PP1 is required for C2D137A dephosphorylation (Figure 5F).
We were able to reinforce these conclusions in vitro using re-
combinant components; addition of excess His-14-3-3z was
sufficient to block dephosphorylation of GST-C2 pro by His-
PP1 in buffer (Figure 3H, last two lanes). In agreement with the
idea that 14-3-3z binding controls C2 dephosphorylation (rather
than vice versa), addition of sufficient OA to inhibit PP1 did not
interfere with 14-3-3z release, suggesting that these are sepa-
rable events (Figure 5G, upper panel).
14-3-3 z Release Is Metabolically Regulated
As described above, G6P blocks C2 dephosphorylation and
activation, yet PP1 was not metabolically regulated. SinceDeveS135 dephosphorylation was more rapid in the absence of
14-3-3z, this suggested that metabolic suppression of C2 might
result from a block in 14-3-3z removal. As shown in Figure 5H,
14-3-3z release from GST-C2 pro was suppressed in the pres-
ence of G6P even with CaMKII inhibition, demonstrating that
CaMKII activity and 14-3-3z release are completely separable.
Finally, if 14-3-3z removal is the point of metabolic control,
then C2 D137A should not be susceptible to metabolic
suppression of C2 pS135. This was, in fact, the case as
dephosphorylation of GST-C2 pro D137A rapidly proceeded
regardless of G6P treatment. Moreover, D137 dephosphoryla-
tion occurred despite inhibition of cyt c release by Bcl-xL to
prevent downstream apoptotic events (Figure 6A; note that
G6P and Bcl-xL were used at sufficient concentrations to
suppress endogenous apoptosis). We also show in Figure 6B
that in vitro-translated full-length C2 D137A was readily pro-
cessed in the presence of G6P, whereas C2 WT was not,
demonstrating that 14-3-3z binding was critical for C2 suppres-
sion by metabolism.
Furthermore, GST-C2 pro D137A prephosphorylated at S135
was readily susceptible to recombinantPP1 invitro,demonstratinglopmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevier Inc. 861
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14-3-3z Regulates Caspase-2 ActivationFigure 5. 14-3-3z Binding Prevents C2
Dephosphorylation
(A) Upper panel: glutathione Sepharose-bound
GST-C2 pro was prebound to endogenous 14-3-
3z and then incubated in fresh extract; samples
were analyzed for 14-3-3 binding. The membrane
was coprobed with a GST antibody. In parallel,
glutathione Sepharose-bound GST-C2 pro was
prephosphorylated with [g-32P]ATP and incu-
bated in extract. Samples were analyzed by auto-
radiography (data not shown). The results of these
experiments are depicted quantitatively (lower
panel; a representative experiment of n = 3).
(B) Upper panel: glutathione Sepharose-bound
GST-C2 pro was prephosphorylated with
[g-32P]ATP and incubated in extracts with control
conditions, His-14-3-3zWT, or His-14-3-3z K49E.
Samples were analyzed by autoradiography.
Quantitation of GST-C2 pro phosphorylation is
provided relative to total protein (lower panel;
a representative experiment of n = 4).
(C) Glutathione Sepharose-bound GST, GST-C2
pro WT, S135A, or D137A was incubated in
extract plus G6P, and affinity-purified proteins
were resolved by SDS-PAGE and immunoblotted
for 14-3-3.
(D) Glutathione Sepharose-bound GST, GST-C2
pro WT, or D137A was phosphorylated with
CaMKII and [g-32P]ATP in buffer. Sepharose-
boundproteinswereanalyzedbyautoradiography.
Black arrow, GST-C2 pro; white arrow, GST.
(E) Glutathione Sepharose-boundGST-C2 proWT
or D137A was prephosphorylated with [g-32P]ATP
and incubated in extracts. Samples were retrieved
over time and analyzed by autoradiography (n = 3).
(F) Glutathione Sepharose-bound GST-C2 pro
D137A was prephosphorylated with [g-32P]ATP.
In parallel, extracts were depleted of endogenous
PP1 with GST- or GST-I2 (extent of PP1 depletion
is demonstrated in [D], the experiment for which
was performed in parallel). Prephosphorylated
GST-C2 pro D137A was incubated in depleted
extracts, and samples were resolved by SDS-
PAGE and detected by autoradiography (n = 2).
(G) Glutathione Sepharose-bound GST-C2 pro was incubated in extract plus G6P to promote binding of endogenous 14-3-3z. Sepharose-bound GST-C2 pre-
bound to endogenous 14-3-3z was incubated in fresh extract in the presence of either OA or G6P. Sepharose-bound proteins were analyzed for 14-3-3 binding
by immunoblotting (n = 3).
(H) Upper panel: glutathione Sepharose-bound GST-C2 pro was prebound to endogenous 14-3-3z and incubated in extract with or without G6P and EGTA
(5 mM). Samples were analyzed for 14-3-3 binding by immunoblotting. Lower left panel: in parallel, GST-C2 pro was incubated in extracts with [g-32P]ATP
with or without G6P and EGTA; samples were analyzed by autoradiography. Lower right panel: samples of G6P and EGTA-treated extracts were analyzed
for CaMKII activation by immunoblotting for CaMKII pT286 (n = 3).that this mutation did not interfere with PP1 binding or activity
(Figure 6C). Consistent with these observations, microinjection
of full-length C2 D137A mRNA into Xenopus oocytes induced
death more robustly than injection of WT (Figure 6D). Therefore,
activation of C2 upon nutrient depletion relies upon removal of
14-3-3z; when this point of control cannot be exerted (D137A
mutant), C2 activation is uncoupled from the nutrient status of
the cell.
Metabolic Regulation of C2 Is Conserved
in the Mammalian Oocyte
Although our data indicate that C2 phosphorylation and 14-3-3
binding were crucial for inhibition of Xenopus oocyte death, we
wished to determine whether this might also be important for862 Developmental Cell 16, 856–866, June 16, 2009 ª2009 Elseviermouse oocyte survival, particularly given the presence of
excess oocytes in C2 knockout mice (Bergeron et al., 1998).
We first identified a metabolically regulated phosphorylation
site on mouse C2 (mC2). Since it is impossible to obtain
sufficient mouse oocytes for biochemical experiments, we
used Xenopus egg extract as a tool for identifying mC2 phos-
phorylation sites. Incubation of GST-mC2 pro WT or candidate
phospho mutants in extract with G6P identified S164 as
a potential site (Figure 7A). Moreover, an in vitro CaMKII assay
also suggested that GST-mC2 pro S164 might be a CaMKII
target (Figure 7B). Furthermore, GST-mC2 pro S164A was
shown to be deficient in 14-3-3 binding, and a 14-3-3 binding
mutant analogous to Xenopus C2 D137A (D166A) was vali-
dated (Figure 7C; it is important to note that, like XenopusInc.
Developmental Cell
14-3-3z Regulates Caspase-2 ActivationC2, the mC2 14-3-3-binding sequence is also noncanonical).
We tested full-length mC2 constructs by microinjection into
Xenopus oocytes and observed that mC2 S164A behaved
much like Xenopus C2 S135A in inducing robust oocyte death
(Figures 7D and 7E).
In Xenopus oocytes, NADPH generation by the PPP promotes
CaMKII activity and phosphorylation of C2 S135. Accordingly,
we previously reported that full-length C2 WT mRNA injected
into oocytes was rapidly suppressed via PPP flux (Nutt et al.,
2005). In contrast, concomitant microinjection of a CaMKII inhib-
itor, negating the contribution of NADPH, enhanced the potency
of C2. To determine if similar regulation was conserved in
mammals, we examined mC2 in the context of mouse egg
apoptosis. In fresh postovulatory mouse eggs, where we would
expect abundant NADPH andCaMKII activity, overexpression of
full-length mC2WT induced death more slowly than mC2 S164A
(homologous to Xenopus S135 [Figure 7F]). Also similar to Xen-
opus C2, the mC2 14-3-3 binding mutant was more potent
than WT (Figure 7G).
A decrease in G6P dehydrogenase activity has been demon-
strated in agedmouse oocytes (de Schepper et al., 1987). There-
fore, we speculated that age-related decreases in PPP fluxmight
sensitize mouse eggs to C2-dependent death. As predicted,
postovulatory-aged eggs were markedly more susceptible
Figure 6. The Interaction Between C2 and
14-3-3z Is Metabolically Regulated
(A) Upper panel: glutathione Sepharose-bound
GST-C2 pro D137A was prephosphorylated with
[g-32P]ATP and incubated in extracts with or
without G6P or Bcl-xL. Samples of Sepharose-
bound proteins were analyzed by autoradiog-
raphy. Lower panel: in parallel, extracts treated
with the same conditions were analyzed for C3
activity using the caspase substrate, Ac-DEVD-
pNA (a representative experiment of n = 3).
(B) Radiolabeled in vitro-translated full-length C2
WT or D137 was incubated in extracts with or
without G6P. Samples were retrieved over time
and analyzed by SDS-PAGE and autoradiog-
raphy.
(C) Glutathione Sepharose-bound GST-C2 pro
D137A was prephosphorylated with [g-32P]ATP
and incubated in buffer with His-PP1 that had
been preincubated in extract. Samples of Sephar-
ose-bound proteins were analyzed by autoradiog-
raphy. The experiment shown is a representative
blot of two distinct experiments.
(D) Percent survival of Xenopus oocytes microin-
jected with full-length C2 WT or D137A mRNA
(a representative experiment of n = 3).
than fresh eggs to death induced by WT
C2 (Figures 7H and 7I; note that mC2
S164A and D166Awere alsomore potent
in aged oocytes, as expected, suggest-
ing that additional cell death-inhibitory
factorsmay be inactivated, or stimulatory
factors activated during aging). These
data demonstrate that our observations
in Xenopus oocytes were conserved in
the murine egg, suggesting that decreases in metabolism may
contribute to oocyte death during aging.
DISCUSSION
The role of C2 in oocyte death was established by experiments
demonstrating that C2 knockout mice are characterized by
excess oocytes (Bergeron et al., 1998). Subsequently, we have
reported that C2 is inhibited when oocyte nutrients are sufficient
to stimulate PPP-mediated NADPH production, which promotes
CaMKII-mediated phosphorylation and inhibition of C2. In this
report, we demonstrate that C2 activation is also under tight
metabolic control. Removal of the suppressive C2 S135 phos-
phorylation is catalyzed by PP1, but this step is not metabolically
regulated. Rather, the point of metabolic control is at the level of
14-3-3z, the removal of which is required for C2 S135 dephos-
phorylation. These observations suggest that C2 is dormant in
nutrient-replete oocytes until stockpiles are exhausted, thus
engaging a 14-3-3-release pathway to activate C2 and trigger
oocyte death.
We have now demonstrated that PP1 is the C2 S135-directed
phosphatase. The interaction between C2 and PP1 is both direct
and constitutive, and we have mapped the PP1 binding site as
C2 V106/H108. Mutation of this site prevents PP1 binding andDevelopmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevier Inc. 863
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Regulation in the Mouse Egg
(A) Glutathione Sepharose-bound GST-mC2 pro
WT, S24A, S157A, T158A, or S164A was incu-
bated in Xenopus extracts with or without G6P
and [g-32P]ATP. Sepharose-bound proteins were
analyzed by autoradiography.
(B) Glutathione Sepharose-bound GST-mC2
pro WT, S157A, T158A, or S164A was phosphor-
ylated in vitro with CaMKII and [g-32P]ATP.
Sepharose-bound proteins were analyzed by
autoradiography.
(C) Glutathione Sepharose-bound GST-mC2 pro
WT, S164A, or D166A was incubated in Xenopus
extract plus G6P. Sepharose-bound proteins
were analyzed by SDS-PAGE and immunoblotted
for 14-3-3.
(D) Percent survival of Xenopus oocytes microin-
jected with mC2 WT, S164A, or b-globin mRNA
(a representative experiment of n = 3).
(E) Xenopus oocytes microinjected with mC2 WT
or S164A mRNA as described in (D) shown as
representative micrographs. The photomicro-
graph shown is representative of three distinct
experiments.
(F) Percent death of fresh mouse eggs microin-
jected with mC2 WT or S164A mRNA, 19 hr post-
injection (a representative experiment of n = 3).
(G) Percent death of fresh mouse eggs microin-
jected with mC2 WT or D166A mRNA (24 hr
post-injection; this is a separate experiment from
(E) and the time course of death varied somewhat
between batches of eggs) (a representative
experiment of n = 3).
(H) Percent death of aged mouse eggs microin-
jected with mC2 WT or S164A mRNA, 8 hr post-
injection (a representative experiment of n = 3).
(I) Percent death of aged mouse eggs microin-
jected with mC2 WT or D166A mRNA, 6 hr post-
injection (note that death of the aged eggs in G
and H was consistently accelerated relative to
the fresh postovulatory eggs) (a representative
experiment of n = 3).C2 dephosphorylation. Thus, C2 joins a small list of proteins
regulated by PP1 in the absence of a targeting subunit.
Since PP1 binding and activity toward C2 are independent of
metabolism, we deduced that an additional factor(s) must
dictate C2 phosphorylation under these conditions. We now
show that 14-3-3z binding to C2 is under metabolic control,
and a C2 mutant unable to bind 14-3-3z is dephosphorylated
regardless of nutrient status. Therefore, factors controlling
14-3-3z removal from C2 are critical for metabolic control of
oocyte apoptosis.
The mechanism underlying 14-3-3z release from C2 is not yet
clear; 14-3-3 binding regulates the activity of many proapoptotic
proteins, and, in these cases, its release depends upon post-
translational modification (e.g., JNK phosphorylates 14-3-3,
promoting its release from BAD and BAX) (Datta et al., 2000;
Nomura et al., 2003; Sunayama et al., 2005; Tsuruta et al.,
2004; Zha et al., 1996). We have not observed phosphorylation
of 14-3-3z in extract prior to its release from C2. GST-C2 pro
phosphorylated at S135 and incubated in nutrient-depleted864 Developmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevierextract (treated with DHEA to inhibit PPP) is deficient in in vitro
binding of recombinant 14-3-3z, but similarly incubated GST-
14-3-3z protein retains its ability to bind in vitro-translated, phos-
phorylated C2 (L.K.N. and S.K., unpublished data). It may be that
any posttranslational modification necessary for 14-3-3z release
is targeted to C2 itself. We also do not observe C2 pro phosphor-
ylation outside of S135, suggesting that distinct posttranslational
C2modifications or pro binding factorsmay play a role in 14-3-3z
release.
In theXenopus oocyte, overexpression of full-length C2S135A
was a potent inducer of apoptosis when compared with WT.
Young, healthy oocytes contain substantial internal nutrients,
and, as such, we hypothesized that C2 was suppressed by
S135 phosphorylation as it was translated (Nutt et al., 2005). Ex-
tending these studies to the mouse egg, we have now identified
a homologous site on mC2 that appears to be important in the
metabolic regulation of mouse egg apoptosis. It is currently not
clear if somatic mC2 is also regulated through S164 phosphory-
lation, or if this pathway is exclusive to oocytes.Inc.
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activity, overexpression of full-length mC2 WT induced death
more weakly than either the phospho- or 14-3-3-binding
mutants. It has been suggested that activity of the rate-limiting
step in the PPP (G6P dehydrogenase) markedly decreases with
age in mouse oocytes (de Schepper et al., 1987). Along those
lines, we demonstrated that postovulatory-aged mouse eggs
were substantially more sensitive to injection of mC2 than fresh
eggs, most likely due to a decrease in NADPH-dependent CaM-
KII activity. Given these data, it is attractive to speculate that
a loss of PPP operation in vivo may underlie oocyte depletion in
females as they age: over time, oocytes loseG6Pdehydrogenase
activity, thuspromoting adrop inNADPHandconcomitant lossof
CaMKII activity. This would, in essence, remove the metabolic
impediment to 14-3-3 release, thus primingC2 for PP1-mediated
dephosphorylation and activation, and leaving the oocyte readily
susceptible to apoptosis induced by a variety of stressors
(e.g., oxidative damage, waning hormonal stimulation). Taken
together, our observations also raise the interesting possibility
that pathologic alterations inC2-directedPP1 activity or changes
in 14-3-3z levels could contribute to changes in female fertility.
EXPERIMENTAL PROCEDURES
Xenopus Extract and Oocytes
Mature female frogswere induced to lay eggs as described previously (Smythe
and Newport, 1991). Jelly coats were removed with 2% cysteine (pH 8.0), and
eggs were washed three times with Marc’s modified Ringer’s solution (MMR:
1 M NaCl, 20 mM KCl, 10 mM MgSO4, 25 mM CaCl2, 5 mM HEPES [pH 7.8],
0.8 mM EDTA) and three times in egg lysis buffer (ELB: 250 mM sucrose,
2.5 mM MgCl2, 1.0 mM dithiothreitol, 50 mM KCl, 10 mM HEPES [pH 7.7]).
Eggs were centrifuged at 400 3 g, and cytochalasin B (5 mg/ml; Calbiochem),
aprotinin/leupeptin (5 mg/ml), and cycloheximide (50 mg/ml) were added. Lysis
was performed by centrifugation at 10,0003 g for 12 min. Crude cytosolic egg
extracts were supplemented with 2 mM ATP and 20 mM phosphocreatine.
Stage VI oocytes were prepared from frogs primed with pregnant mare
serum gonadotropin 3–5 days before excision of ovaries. Ovaries were di-
gested with 2.8 U liberase (Roche) in OR-2 buffer (82.5 mM NaCl, 2 mM KCl,
1 mM MgCl2, 5 mM HEPES [pH 7.5]) for 1.5 hr at room temperature (RT).
Oocytes were washed with OR-2 buffer and stored in OR-2 plus 1% fetal
bovine serum, 0.2% gentamicin overnight at 18C. Healthy stage VI oocytes
were selected for microinjection.
Recombinant Protein Cloning and Expression
pGEXKG N-terminal GST-Xenopus C2 pro, mC2 pro, 14-3-3z and 3, I2, and
His-PP1 were expressed in BL21 Escherichia coli as described previously
(Gasco et al., 2002).
Xenopus C2 was cloned as previously described into pGEXKG and pSP64T
(Nutt et al., 2005). The Quikchange kit (Stratagene) was used to generate Xen-
opus C2 mutants from the WT template using the primers detailed in the
Supplemental Data.
To produce radiolabeled in vitro-translated protein, pSP64T C2 cDNA was
added at 20 ng/ml to rabbit TNT reticulocyte lysate (Promega) containing
0.4 mCi/ml 35S-Translabel, 13 (minus-Cys, minus-Met) amino acid mix, and
additional components in accordance with the manufacturer’s protocol.
Antibodies
Anti-PP1 (polyclonal, 1:1000) and PP2A (monoclonal, 1:2000) antibodies were
purchased from Upstate; anti-cyt c (polyclonal, 1:500) from PharMingen; anti-
14-3-3 (polyclonal, 1:1000) from AbCam, anti-actin (monoclonal, 1:4000) from
Sigma-Aldrich, anti-flag (polyclonal, 1:1000) from Cell Signaling, anti-CaMKII
pT286 (polyclonal, 1:1000) from AbCam, and anti-CaMKII (monoclonal,
1:1000) from BD Transduction Laboratories. Xenopus polyclonal antibodies
were generated as described in the Supplemental Data.DeveCaspase Assay
Egg extract (3 ml) was incubated in 90 ml DEVDase buffer (50 mM HEPES
[pH 7.5], 100 mMNaCl, 0.1%CHAPS, 10 mMDTT, 1 mMEDTA, 10% glycerol)
with the colorimetric peptide substrate, Ac-DEVD-pNA (200 mM final concen-
tration; BIOMOL Research Labs, Inc.). Reactions were incubated at 37C for
30min. Absorbance of the colorimetric product wasmeasured at 405 nmusing
a Bio-Rad microplate reader.
C2 Dephosphorylation Assay
GST-C2 pro (30 mg) was phosphorylated at S135 as follows: glutathione
Sepharose-bound proteins were incubated with recombinant CaM and CaM-
KII in CaMK buffer (1 M HEPES [pH 7.5], 1 M DTT, 1 M MgCl2, 10% Tween,
0.2 M ATP, 1 M CaCl2) in the presence of 10 mCi [g-
32P]ATP. Radiolabeled
GST-C2 pro was then incubated in extract at RT. Samples were washed
with buffer containing salt and detergent, eluted with SDS sample buffer,
resolved on SDS-PAGE, and analyzed by autoradiography.
Cyt c Release Assay
Crude extract (15 ml) was diluted in 15 ml ELB and filtered through a 0.1 mm
ultrafree-MC filter (Millipore). The filtrate was mixed with SDS sample buffer,
resolved by 17.5% SDS-PAGE, and transferred to PVDFmembrane (Millipore,
Bedford, MA). The membrane was probed with an anti-cyt c antibody.
Inhibitor-2 Affinity Depletion of PP1
Xenopus extract was depleted of PP1 by three 1-hr incubations at 4C with
GST or GST-I2 bound to glutathione Sepharose. Depletion was confirmed
by PP1 immunoblotting; anti-actin was used to assure equal loading.
Recombinant Protein Affinity Binding Assay
Recombinant GST-C2 pro (20 mg) or GST-14-3-3 (z and 3, 20 mg) were bound to
glutathione Sepharose and incubated in egg extract. Sepharose-bound
proteins were washed with buffer plus 300 mM NaCl and 0.1% Triton-X,
resolved by SDS-PAGE, and analyzed by immunoblotting.
14-3-3 Release Assay
GST-C2 pro (20 mg) bound to glutathione Sepharose was incubated in extract
plus G6P to promote binding of endogenous 14-3-3z. Sepharose-bound
proteins were retrieved and washed with low-salt buffer. GST-C2 pro with
endogenous 14-3-3zwas then added to fresh extract, and samples of Sephar-
ose-bound proteins were retrieved over time, washed with buffer plus 300 mM
NaCl and 0.1% Triton-X, eluted with SDS sample buffer, resolved by SDS-
PAGE, and analyzed by immunoblotting with a pan-14-3-3 antibody.
Oocyte Injection Assays
pSP64T Xenopus full-length C2 cDNA templates were linearized withXbaI, and
mRNA was generated using the Stratagene mRNA capping kit. Translation
levels were tested with TNT reticulocyte lysate in vitro translation, as described
above, or affinity precipitation from translationally competent egg extract,
where specified.
mC2 was cloned into pSP64T and mRNA was produced as previously
described (Kurokawa et al., 2007). In brief, the cDNAs were linearized with
XbaI and transcribed in vitro using the mMessage/mMachine capping kit (Am-
bion, Austin, TX). Mouse oocytes were collected and microinjected with mC2
mRNA as previously described (Fissore et al., 2002; Kurokawa et al., 2007).
Additional Reagents
D-Glucose 6-phosphate sodium salt (Sigma-Aldrich) was used at 10 mM.
Okadaic acid (Sigma-Aldrich) was used at 10 mM, unless otherwise indicated.
Glutathione Sepharose was purchased from Amersham Biosciences, Dyna-
beads Protein A from Invitrogen, Calmodulin and CaMKII from CalBiochem,
and VDVAD-CHO from BioMol.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and one
figure and can be found with this article online at http://www.cell.com/
developmental-cell/supplemental/S1534-5807(09)00167-1.lopmental Cell 16, 856–866, June 16, 2009 ª2009 Elsevier Inc. 865
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